Metformin inhibits proliferation and enhances chemosensitivity of intrahepatic cholangiocarcinoma cell lines
Sunbin Ling(Blood Center of Zhejiang Province), Liming Wang(Second Affiliated Hospital of Dalian Medical University)
Cited by 62
Related Papers
USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway
|Molecular Oncology|2017|106
Combination of metformin and sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway
|International Journal of Oncology|2016|97
Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I
|Cell Death and Disease|2017|60